| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| S Denis-Donini, J Glowinski, A Prochiant. Specific influence of striatal target neurons on the in vitro outgrowth of mesencephalic dopaminergic neurites: a morphological quantitative study. The Journal of neuroscience : the official journal of the Society for Neuroscience. vol 3. issue 11. 1983-12-17. PMID:6631481. |
in previous studies, we have shown that dissociated dopaminergic neurons from embryonic mouse in co-culture with striatal target neurons take up and synthesize dopamine to a greater extent. |
1983-12-17 |
2023-08-12 |
mouse |
| S Yamawaki, H Lai, A Horit. Dopaminergic and serotonergic mechanisms of thermoregulation: mediation of thermal effects of apomorphine and dopamine. The Journal of pharmacology and experimental therapeutics. vol 227. issue 2. 1983-12-17. PMID:6631720. |
dopaminergic and serotonergic mechanisms of thermoregulation: mediation of thermal effects of apomorphine and dopamine. |
1983-12-17 |
2023-08-12 |
rat |
| L A Kamal, S Arbilla, A M Galzin, S Z Lange. Amphetamine inhibits the electrically evoked release of [3H]dopamine from slices of the rabbit caudate. The Journal of pharmacology and experimental therapeutics. vol 227. issue 2. 1983-12-17. PMID:6631724. |
these results indicate that the inhibition by amphetamine of the electrically evoked release of [3h]dopamine does not involve the activation of presynaptic inhibitory dopamine autoreceptors possibly located on dopaminergic nerve terminals. |
1983-12-17 |
2023-08-12 |
rabbit |
| J M Farah, K T Demarest, K E Moor. A comparison of domperidone and haloperidol effects on different dopaminergic neurons in the rat brain. Life sciences. vol 33. issue 16. 1983-12-17. PMID:6633157. |
domperidone, a dopamine (da) receptor antagonist with reportedly preferential actions outside of the blood-brain barrier, and haloperidol, a centrally active da antagonist, were compared with respect to their abilities to increase the activity of dopaminergic neurons in the rat brain. |
1983-12-17 |
2023-08-12 |
rat |
| F Nicoletti, F Drago, C Speciale, L G Kovacs, U Scapagnin. Role of prolactin-opiate interactions in the central regulation of pain threshold. Cephalalgia : an international journal of headache. vol 3 Suppl 1. 1983-11-23. PMID:6311424. |
the apparent analgesic effect of prolactin has been related to the stimulation of nigro-striatal dopaminergic transmission, as suggested by the increase in striatal dopamine turnover observed in hyperprolactinaemic rats. |
1983-11-23 |
2023-08-12 |
rat |
| P Preziosi, F Cerrito, M Vacc. Etomidate inhibits prolactin release but not through a dopaminergic mechanism. Brain research. vol 271. issue 2. 1983-11-23. PMID:6604560. |
studies performed on superfused synaptosomes from brain areas rich in dopaminergic nerve endings did not show any influence of the etomidate, 10(-7) m-10(-6) m, on [3h]dopamine release. |
1983-11-23 |
2023-08-12 |
rat |
| F Ponzio, G Achilli, C Perego, G Rinaldi, S Alger. Does acute L-DOPA increase active release of dopamine from dopaminergic neurons? Brain research. vol 273. issue 1. 1983-11-23. PMID:6616231. |
does acute l-dopa increase active release of dopamine from dopaminergic neurons? |
1983-11-23 |
2023-08-12 |
Not clear |
| F Ponzio, G Achilli, C Perego, G Rinaldi, S Alger. Does acute L-DOPA increase active release of dopamine from dopaminergic neurons? Brain research. vol 273. issue 1. 1983-11-23. PMID:6616231. |
l-dopa is believed to be decarboxylated by the residual striatal dopaminergic presynaptic terminals with formation of the putative neurotransmitter dopamine (da) and with increased availability of da at post-synaptic receptors. |
1983-11-23 |
2023-08-12 |
Not clear |
| M F Chesselet, A Cheramy, R Romo, M Desban, J Glowinsk. GABA in the thalamic motor nuclei modulates dopamine release from the two dopaminergic nigrostriatal pathways in the cat. Experimental brain research. vol 51. issue 2. 1983-11-23. PMID:6617796. |
gaba in the thalamic motor nuclei modulates dopamine release from the two dopaminergic nigrostriatal pathways in the cat. |
1983-11-23 |
2023-08-12 |
cat |
| R J Dinerstein, R T Jones, L I Goldber. Evidence for dopamine-containing renal nerves. Federation proceedings. vol 42. issue 13. 1983-11-23. PMID:6617896. |
the existence of the specific renal da1 postsynaptic receptor for dopamine (da) has prompted the search for a counterpart dopaminergic innervation. |
1983-11-23 |
2023-08-12 |
rat |
| K Racké, E Muschol. Uptake of [3H]dopamine into dopaminergic and noradrenergic neurones of the isolated neurointermediate lobe of the rat hypophysis. Effects of desipramine and nomifensine. Journal of neurochemistry. vol 41. issue 5. 1983-11-23. PMID:6619880. |
uptake of [3h]dopamine into dopaminergic and noradrenergic neurones of the isolated neurointermediate lobe of the rat hypophysis. |
1983-11-23 |
2023-08-12 |
rat |
| K Racké, E Muschol. Uptake of [3H]dopamine into dopaminergic and noradrenergic neurones of the isolated neurointermediate lobe of the rat hypophysis. Effects of desipramine and nomifensine. Journal of neurochemistry. vol 41. issue 5. 1983-11-23. PMID:6619880. |
thus, in the nil, [3h]dopamine is taken up into dopaminergic and noradrenergic neurones. |
1983-11-23 |
2023-08-12 |
rat |
| E Carboni, M Memo, P F Span. Differential affinity of dopaminergic agonists and antagonists for D1 and D2 dopamine receptors in rat striatum. Pharmacological research communications. vol 15. issue 7. 1983-11-23. PMID:6622515. |
differential affinity of dopaminergic agonists and antagonists for d1 and d2 dopamine receptors in rat striatum. |
1983-11-23 |
2023-08-12 |
rat |
| A M Nielsen, G E Bisgar. Dopaminergic modulation of respiratory timing mechanisms in carotid body-denervated dogs. Respiration physiology. vol 53. issue 1. 1983-11-23. PMID:6622865. |
in contrast, apomorphine (apo), a potent dopaminergic agonist, which unlike dopamine, crosses the blood-brain barrier consistently and significantly prolonged inspiratory duration and shortened expiratory duration without altering phrenic amplitude. |
1983-11-23 |
2023-08-12 |
Not clear |
| J L Elghoz. [Role of hypothalamic dopamine in blood pressure regulation]. Annales de medecine interne. vol 134. issue 3. 1983-11-23. PMID:6625421. |
dopamine has a central hypotensive effect which can be reproduced by the administration of dopaminergic agonists which cross the blood-brain barrier. |
1983-11-23 |
2023-08-12 |
Not clear |
| S P Bagch. Differential interactions of phencyclidine with tetrabenazine and reserpine affecting intraneuronal dopamine. Biochemical pharmacology. vol 32. issue 19. 1983-11-23. PMID:6626259. |
in summary, tetrabenazine and reserpine affected synaptosomal dopamine formation and release in a comparable manner, but intraneuronal dopaminergic actions of phencyclidine and also of amfonelic acid may be influenced differentially by these two releasing agents. |
1983-11-23 |
2023-08-12 |
Not clear |
| S K Rastogi, R B Rastogi, R L Singhal, Y D Lapierr. Behavioural and biochemical alterations following haloperidol treatment and withdrawal: the animal model of tardive dyskinesia reexamined. Progress in neuro-psychopharmacology & biological psychiatry. vol 7. issue 2-3. 1983-10-28. PMID:6137027. |
these data suggest that chronic haloperidol treatment and subsequent withdrawal results in the development of behavioural dopamine supersensitivity as well as biochemical alterations in dopaminergic and gabaergic system. |
1983-10-28 |
2023-08-12 |
rat |
| K Negishi, T Teranishi, S Kat. A GABA antagonist, bicuculline, exerts its uncoupling action on external horizontal cells through dopamine cells in carp retina. Neuroscience letters. vol 37. issue 3. 1983-10-28. PMID:6310453. |
these uncoupling actions of bcc were similar to those of amphetamine (20 microm) or dopamine (10-20 microm) and were abolished by the presence of a dopaminergic blocker, haloperidol (20-40 microm). |
1983-10-28 |
2023-08-12 |
Not clear |
| J H Tinke. Beta-adrenergic agonists and antagonists. Contemporary anesthesia practice. vol 7. 1983-10-21. PMID:6136394. |
overriding in adults, at least, may be the ability of dopamine to stimulate renal dopaminergic receptors to increase renal blood flow. |
1983-10-21 |
2023-08-12 |
Not clear |
| O B Holland, C Thomas, H Brown, D Schindewolf, Y Hillier, C Gomez-Sanche. Aldosterone suppression with dopamine infusion in low-renin hypertension. The Journal of clinical investigation. vol 72. issue 3. 1983-10-21. PMID:6309909. |
to assess the possibility that a defect in the dopaminergic mechanism might enhance aldosterone secretion in hypertensive patients, we determined basal and adrenocorticotropic hormone (acth)-stimulated plasma aldosterone (pa), cortisol, renin activity, and potassium concentrations before and during dopamine receptor stimulation with dopamine infusion and bromocriptine administration and dopamine receptor blockade with metoclopramide. |
1983-10-21 |
2023-08-12 |
Not clear |